You Searched For:

基因治疗中的上游工艺 Achieve optimal generation of gene therapy vectors with our non-viral transfection and viral transduction products. Avantor® can provide culture systems that support processes development scale-up and full manufacturing. 我们的系统包括： 转染和电穿孔...

Plant Media Formulations Growth Regulators and Antibiotics 1 CASE STUDY Pollen Natural Method for Allergen Identification using FastPrep-24™ 5G technology Andrea Brazdova Oumsaad Naas Nicolas Visez Jean-Pierre Sutra Hélène Sénéchal et Pascal Ponce...

Plant Media Formulations Growth Regulators and Antibiotics 1 CASE STUDY Pollen Natural Method for Allergen Identification using FastPrep-24™ 5G technology Andrea Brazdova Oumsaad Naas Nicolas Visez Jean-Pierre Sutra Hélène Sénéchal et Pascal Ponce...

Plant Media Formulations Growth Regulators and Antibiotics 1 CASE STUDY Pollen Natural Method for Allergen Identification using FastPrep-24™ 5G technology Andrea Brazdova Oumsaad Naas Nicolas Visez Jean-Pierre Sutra Hélène Sénéchal et Pascal Ponce...

Upstream processing for gene therapy Achieve optimal generation of gene therapy vectors with our non-viral transfection and viral transduction products. Avantor® can provide culture systems that support processes development scale-up and full manu...

1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...

1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...

1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...

1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...

Plant Media Formulations Growth Regulators and Antibiotics 1 CASE STUDY Pollen Natural Method for Allergen Identification using FastPrep-24™ 5G technology Andrea Brazdova Oumsaad Naas Nicolas Visez Jean-Pierre Sutra Hélène Sénéchal et Pascal Ponce...

Plant Media Formulations Growth Regulators and Antibiotics 1 CASE STUDY Pollen Natural Method for Allergen Identification using FastPrep-24™ 5G technology Andrea Brazdova Oumsaad Naas Nicolas Visez Jean-Pierre Sutra Hélène Sénéchal et Pascal Ponce...

1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...

Upstream Gene Therapy Products & Solutions in Bioprocessing Achieve optimal generation of gene therapy vectors with our non-viral transfection and viral transduction products. Avantor® can provide culture systems that support processes development...

Upstream processing for gene therapy Achieve optimal generation of gene therapy vectors with our non-viral transfection and viral transduction products. Avantor® can provide culture systems that support processes development scale-up and full manu...

1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...